The IPO market for healthcare tech companies is facing its worst year in two decades as the COVID-19 pandemic, Russia’s war in Ukraine, record-high inflation and rising interest rates have squeezed public market valuations and sent stocks plunging.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,